Registry Collecting Data on Children and Young Adults with Eczema
Collects data on people with eczema who use or will use whole-body treatments.
Key facts
- Who runs it
- Johns Hopkins University
- Where
- Baltimore, United StatesSee the site
- Trial code
- Registry title
- Registry for Systemic Eczema Treatments
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 17 Jan 2024
- Expected to end
- 31 Dec 2030
- Type of study
- Observational, 8 groups
- Record updated
- 7 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for children and young people under 26 with atopic dermatitis (eczema) who have used, are using, or will soon start a systemic eczema treatment, and who are seen at Johns Hopkins.
- Age
- Under 26 years old (the record lists 1 Year to 26 Years).
- Sex
- All sexes can join.
- Disease stage
- Atopic dermatitis currently diagnosed by a doctor; the registry is for pediatric-onset atopic dermatitis.
- Earlier treatment
- Has taken a systemic atopic dermatitis treatment, is taking one now, or plans to start one within the next 6 months.
Main reasons for not taking part
- Age 26 or older when joining the registry
- Does not speak English, or (if under 18) the main caretaker does not speak English
- Is a foster child
- Has not received care at Johns Hopkins since 1/1/2017
- If under 18, the parent or legal guardian is unwilling to sign written consent
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age <26 years old
- Current physician diagnosis of atopic dermatitis
- Provide signed informed consent if ≥ 18 years old
- Provide signed informed consent by parent or legal guardian (if <18 years old) and informed assent if applicable
- Subject and/or parent/legal guardian is willing to be contacted in the future by study staff
- Seen for clinical care at Johns Hopkins since 1/1/2017
- Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy
Who cannot take part
- Has not received clinical care at Johns Hopkins since 1/1/2017
- Age ≥26 years old at the time of registry enrollment
- If <18 years old, has a primary caretaker who does not speak English
- If <18 years old, parent/legal guardian is unwilling to sign the written informed consent
- Does not speak English
- Is a foster child
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 1 and 26 years old?
Where in United States
- Johns Hopkins UniversityBaltimore, United StatesContact: Zeena Mestari, BATaking people
About the trial
What the trial wants to find out
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
The 8 groups in the trial
- Methotrexate
Participants who have received methotrexate for atopic dermatitis.
- Cyclosporine
Participants who have received cyclosporine for atopic dermatitis.
- Mycophenolate mofetil
Participants who have received mycophenolate mofetil for atopic dermatitis.
- Azathioprine
Participants who have received azathioprine for atopic dermatitis.
- Dupilumab
Participants who have received dupilumab for atopic dermatitis.
- Tralokinumab
Participants who have received tralokinumab for atopic dermatitis.
- Upadacitinib
Participants who have received upadacitinib for atopic dermatitis.
- Abrocitinib
Participants who have received abrocitinib for atopic dermatitis.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Registry for Systemic Eczema Treatments
- Plain-language title
- Registry Collecting Data on Children and Young Adults with EczemaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06136767, who can take part
- Record updated
- 7 April 2026